Skip to main content

$0.038 0.005 (15.15%)

High

$0.04

Low

$0.03

Trades

55

Turnover

$121,565

Volume

3,767,585
30 June 2023 at 4:10pm
Register to track RSH and receive email alerts.
Subject
RSH Ann: Security Purchase Plan

RSH Ann: Arkansas Heart Hospital commences patients on wheezo RPM

RSH Ann: Change of Director's Interest Notice - MM share acquisition

RSH Ann: Change of Director's Interest Notice - NS share acquisition

RSH Ann: wheezo RPM program expands into New Mexico USA

RSH Ann: Disclosure Document - Cleansing Notice

RSH Ann: Application for quotation of securities - RSH

RSH Ann: First patients selected and enrolled into Minnesota Lung Ctr

RSH Ann: First primary care practice secured and first patients

RSH Ann: wheezo RPM program selected by leading USA heart center

RSH Ann: Minnesota Lung Centre select wheezo and RMP for pilot prog.

RSH Ann: Constitution

RSH Ann: Results of 2022 Annual General Meeting

RSH Ann: Chairman and CEO's Presentation to Shareholders

RSH Ann: Key milestone - First patients enrol into wheezo RPM program

RSH Ann: Quarterly Activities/Appendix 4C Cash Flow Report

RSH Ann: Notice of Annual General Meeting/Proxy Form

RSH Ann: Notification of cessation of securities - RSH

RSH Ann: Disclosure Document - Cleansing Notice

RSH Ann: Application for quotation of securities - RSH

RSH Ann: Cost optimisation with senior executive remuneration

RSH Ann: Respiri commences trading on the OTCQB

RSH Ann: Update - Proposed issue of securities - RSH

RSH Ann: Centre of Digital Innovation Excellence established

RSH Ann: Proposed issue of securities - RSH

RSH Ann: Placement of $1.6m to Support US Expansion

RSH Ann: Trading Halt

RSH Ann: Annual Report to shareholders

RSH Ann: Preliminary Final Report

RSH Ann: Appendix 4G and Corporate Governance Statement

RSH Ann: Investor USA market update and presentation

RSH Ann: Investor webinar invitation - US business update

RSH Ann: Company Secretary Appointment/Resignation

RSH Ann: Investor presentation invitation

RSH Ann: Monthly Activities/Appendix 4C Cash Flow Report

RSH Ann: Wheezo successfully integrated in Michigan Children Hospital

RSH Ann: Presentation at Innovate Health 2022 Conference

RSH Ann: Investor presentation

RSH Ann: Investor Webinar 15 July 2022

RSH Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial

RSH Ann: Cleansing Notice

RSH Ann: Change in substantial holding

RSH Ann: US med-tech executive appointed Non-Executive Director

RSH Ann: Application for quotation of securities - RSH

RSH Ann: Notification regarding unquoted securities - RSH

RSH Ann: Proposed issue of securities - RSH

RSH Ann: Notification regarding unquoted securities - RSH

RSH Ann: Placement - cleansing notice

RSH Ann: Application for quotation of securities - RSH

RSH Ann: Notification of cessation of securities - RSH

Register to track RSH and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
SOM